US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 605.610
  • +15.610+2.65%
Close May 2 16:00 ET
  • 605.610
  • 0.0000.00%
Post 16:05 ET
65.38BMarket Cap15.39P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
-3.70%3.03B
8.27%14.2B
10.33%3.79B
10.65%3.72B
12.32%3.55B
-0.54%3.15B
7.76%13.12B
0.58%3.43B
14.53%3.36B
10.53%3.16B
Operating revenue
-2.68%2.95B
8.79%13.69B
12.04%3.61B
11.85%3.61B
11.45%3.44B
-0.59%3.03B
6.55%12.58B
-1.97%3.22B
13.06%3.22B
10.39%3.09B
Cost of revenue
7.03%464.3M
8.52%1.97B
9.36%565.4M
12.53%491.1M
18.60%480.2M
-5.18%433.8M
16.37%1.82B
-4.37%517M
37.32%436.4M
36.28%404.9M
Gross profit
-5.41%2.56B
8.23%12.23B
10.51%3.22B
10.36%3.23B
11.39%3.07B
0.24%2.71B
6.49%11.3B
1.51%2.92B
11.76%2.93B
7.54%2.75B
Operating expense
0.66%1.97B
13.60%8.24B
14.87%2.23B
12.93%2.05B
15.01%2B
11.49%1.96B
23.51%7.25B
12.59%1.94B
30.16%1.82B
19.76%1.74B
Selling and administrative expenses
-8.13%633M
12.28%2.95B
7.39%792.2M
11.54%714.4M
16.38%758.8M
14.62%689M
24.36%2.63B
11.69%737.7M
21.05%640.5M
36.89%652M
Research and development costs
6.71%1.34B
13.14%5.23B
18.12%1.43B
12.97%1.33B
12.77%1.22B
8.49%1.26B
20.21%4.63B
12.50%1.21B
28.97%1.18B
9.48%1.09B
Other operating expenses
----
2,642.86%53.4M
3,200.00%15.5M
1,700.00%8M
2,533.33%14.6M
3,160.00%15.3M
97.66%-2.1M
92.42%-500K
98.91%-500K
96.55%-600K
Operating profit
-21.25%591.7M
-1.39%3.99B
1.78%990.2M
6.17%1.18B
5.22%1.07B
-20.63%751.4M
-14.60%4.05B
-15.16%972.9M
-9.21%1.11B
-8.42%1.02B
Net non-operating interest income expense
13.34%164.8M
55.17%656.2M
32.36%172.6M
49.78%173.6M
65.59%164.6M
88.34%145.4M
319.96%422.9M
145.57%130.4M
319.93%115.9M
558.28%99.4M
Non-operating interest income
7.43%173.5M
43.46%711.4M
23.13%183.1M
40.16%187.4M
51.65%179.4M
69.64%161.5M
209.74%495.9M
110.92%148.7M
211.66%133.7M
319.50%118.3M
Non-operating interest expense
-45.96%8.7M
-24.38%55.2M
-42.62%10.5M
-22.47%13.8M
-21.69%14.8M
-10.56%16.1M
22.90%73M
5.17%18.3M
16.34%17.8M
44.27%18.9M
Other net income (expense)
175.73%148.5M
149.13%133M
-562.08%-204.7M
220.50%139.9M
1,293.64%393.9M
-18.20%-196.1M
-1,509.90%-270.7M
-64.50%44.3M
-144.91%-116.1M
79.60%-33M
Gain on sale of security
171.20%139.7M
146.75%117.2M
-572.57%-213.6M
234.10%134.5M
1,370.23%392.5M
-19.13%-196.2M
-2,510.58%-250.7M
-65.50%45.2M
-139.44%-100.3M
81.12%-30.9M
Special income (charges)
----
45.73%-101M
54.00%-13.8M
43.80%-56.2M
---23.9M
87.34%-7.1M
27.05%-186.1M
0.00%-30M
---100M
--0
-Less:Other special charges
----
-45.73%101M
-54.00%13.8M
-43.80%56.2M
--23.9M
-87.34%7.1M
-27.05%186.1M
0.00%30M
--100M
----
Other non- operating income (expenses)
8,700.00%8.8M
179.00%15.8M
1,088.89%8.9M
134.18%5.4M
166.67%1.4M
108.33%100K
-327.27%-20M
85.48%-900K
-476.19%-15.8M
-210.53%-2.1M
Income before tax
29.16%905M
13.83%4.78B
-16.51%958.1M
34.41%1.49B
50.35%1.63B
-18.33%700.7M
-13.57%4.2B
-13.37%1.15B
-26.43%1.11B
12.43%1.08B
Income tax
552.11%96.3M
49.49%367.3M
436.67%40.4M
47.96%152.4M
71.00%195.8M
-152.99%-21.3M
-52.79%245.7M
-109.40%-12M
-46.93%103M
3.06%114.5M
Net income
12.01%808.7M
11.61%4.41B
-20.86%917.7M
33.02%1.34B
47.90%1.43B
-11.71%722M
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
Net income continuous Operations
12.01%808.7M
11.61%4.41B
-20.86%917.7M
33.02%1.34B
47.90%1.43B
-11.71%722M
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
Minority interest income
Net income attributable to the parent company
12.01%808.7M
11.61%4.41B
-20.86%917.7M
33.02%1.34B
47.90%1.43B
-11.71%722M
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.01%808.7M
11.61%4.41B
-20.86%917.7M
33.02%1.34B
47.90%1.43B
-11.71%722M
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
Basic earnings per share
13.13%7.58
10.39%40.9
-21.60%8.53
30.80%12.4
46.41%13.25
-12.30%6.7
-8.54%37.05
-2.77%10.88
-22.99%9.48
14.56%9.05
Diluted earnings per share
15.95%7.27
10.27%38.34
-20.90%8.06
29.81%11.54
46.00%12.41
-12.55%6.27
-9.03%34.77
-2.95%10.19
-23.76%8.89
13.79%8.5
Dividend per share
0.88
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue -3.70%3.03B8.27%14.2B10.33%3.79B10.65%3.72B12.32%3.55B-0.54%3.15B7.76%13.12B0.58%3.43B14.53%3.36B10.53%3.16B
Operating revenue -2.68%2.95B8.79%13.69B12.04%3.61B11.85%3.61B11.45%3.44B-0.59%3.03B6.55%12.58B-1.97%3.22B13.06%3.22B10.39%3.09B
Cost of revenue 7.03%464.3M8.52%1.97B9.36%565.4M12.53%491.1M18.60%480.2M-5.18%433.8M16.37%1.82B-4.37%517M37.32%436.4M36.28%404.9M
Gross profit -5.41%2.56B8.23%12.23B10.51%3.22B10.36%3.23B11.39%3.07B0.24%2.71B6.49%11.3B1.51%2.92B11.76%2.93B7.54%2.75B
Operating expense 0.66%1.97B13.60%8.24B14.87%2.23B12.93%2.05B15.01%2B11.49%1.96B23.51%7.25B12.59%1.94B30.16%1.82B19.76%1.74B
Selling and administrative expenses -8.13%633M12.28%2.95B7.39%792.2M11.54%714.4M16.38%758.8M14.62%689M24.36%2.63B11.69%737.7M21.05%640.5M36.89%652M
Research and development costs 6.71%1.34B13.14%5.23B18.12%1.43B12.97%1.33B12.77%1.22B8.49%1.26B20.21%4.63B12.50%1.21B28.97%1.18B9.48%1.09B
Other operating expenses ----2,642.86%53.4M3,200.00%15.5M1,700.00%8M2,533.33%14.6M3,160.00%15.3M97.66%-2.1M92.42%-500K98.91%-500K96.55%-600K
Operating profit -21.25%591.7M-1.39%3.99B1.78%990.2M6.17%1.18B5.22%1.07B-20.63%751.4M-14.60%4.05B-15.16%972.9M-9.21%1.11B-8.42%1.02B
Net non-operating interest income expense 13.34%164.8M55.17%656.2M32.36%172.6M49.78%173.6M65.59%164.6M88.34%145.4M319.96%422.9M145.57%130.4M319.93%115.9M558.28%99.4M
Non-operating interest income 7.43%173.5M43.46%711.4M23.13%183.1M40.16%187.4M51.65%179.4M69.64%161.5M209.74%495.9M110.92%148.7M211.66%133.7M319.50%118.3M
Non-operating interest expense -45.96%8.7M-24.38%55.2M-42.62%10.5M-22.47%13.8M-21.69%14.8M-10.56%16.1M22.90%73M5.17%18.3M16.34%17.8M44.27%18.9M
Other net income (expense) 175.73%148.5M149.13%133M-562.08%-204.7M220.50%139.9M1,293.64%393.9M-18.20%-196.1M-1,509.90%-270.7M-64.50%44.3M-144.91%-116.1M79.60%-33M
Gain on sale of security 171.20%139.7M146.75%117.2M-572.57%-213.6M234.10%134.5M1,370.23%392.5M-19.13%-196.2M-2,510.58%-250.7M-65.50%45.2M-139.44%-100.3M81.12%-30.9M
Special income (charges) ----45.73%-101M54.00%-13.8M43.80%-56.2M---23.9M87.34%-7.1M27.05%-186.1M0.00%-30M---100M--0
-Less:Other special charges -----45.73%101M-54.00%13.8M-43.80%56.2M--23.9M-87.34%7.1M-27.05%186.1M0.00%30M--100M----
Other non- operating income (expenses) 8,700.00%8.8M179.00%15.8M1,088.89%8.9M134.18%5.4M166.67%1.4M108.33%100K-327.27%-20M85.48%-900K-476.19%-15.8M-210.53%-2.1M
Income before tax 29.16%905M13.83%4.78B-16.51%958.1M34.41%1.49B50.35%1.63B-18.33%700.7M-13.57%4.2B-13.37%1.15B-26.43%1.11B12.43%1.08B
Income tax 552.11%96.3M49.49%367.3M436.67%40.4M47.96%152.4M71.00%195.8M-152.99%-21.3M-52.79%245.7M-109.40%-12M-46.93%103M3.06%114.5M
Net income 12.01%808.7M11.61%4.41B-20.86%917.7M33.02%1.34B47.90%1.43B-11.71%722M-8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M
Net income continuous Operations 12.01%808.7M11.61%4.41B-20.86%917.7M33.02%1.34B47.90%1.43B-11.71%722M-8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M
Minority interest income
Net income attributable to the parent company 12.01%808.7M11.61%4.41B-20.86%917.7M33.02%1.34B47.90%1.43B-11.71%722M-8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.01%808.7M11.61%4.41B-20.86%917.7M33.02%1.34B47.90%1.43B-11.71%722M-8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M
Basic earnings per share 13.13%7.5810.39%40.9-21.60%8.5330.80%12.446.41%13.25-12.30%6.7-8.54%37.05-2.77%10.88-22.99%9.4814.56%9.05
Diluted earnings per share 15.95%7.2710.27%38.34-20.90%8.0629.81%11.5446.00%12.41-12.55%6.27-9.03%34.77-2.95%10.19-23.76%8.8913.79%8.5
Dividend per share 0.88
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Meta Platforms
META
597.020
Oracle
ORCL
150.730
Strategy
MSTR
394.370
4
Toll Brothers
TOL
104.330
5
MARA Holdings
MARA
14.480
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.